Asthma Management in Older Adults

Core Recommendations

The American Academy of Family Physicians recommends as-needed SABA monotherapy for patients with intermittent asthma who experience symptoms less than 2 days per week 1, 2, 3
Albuterol is the most commonly prescribed SABA, typically administered as 2 puffs every 4-6 hours when symptoms occur 5
No daily controller medication is indicated at this step 1, 2, 4

SABA use frequency serves as the primary indicator for stepping up therapy, with use more than 2 days per week signaling inadequate asthma control and necessitating advancement to Step 2 therapy with daily low-dose inhaled corticosteroids 1, 2, 3, 4, 6

Patients should be instructed that SABA provides quick relief within minutes but does not treat underlying airway inflammation 4
Proper inhaler technique should be emphasized, as inadequate technique significantly reduces medication effectiveness 7, 6
Patients should be advised to track SABA use frequency, as exceeding 2 days per week indicates need for controller therapy 1, 3, 4
Patients should be educated on recognizing exacerbation warning signs that require urgent medical attention 3, 4

Failing to recognize when SABA use exceeds 2 days per week is a critical error, indicating progression to mild persistent asthma requiring daily controller therapy 1, 3, 4, 6
Prescribing daily controller medications at Step 1 for truly intermittent asthma exposes patients to unnecessary medication side effects without clinical benefit 1, 4

Asthma control should be reassessed at every visit, specifically asking about SABA use frequency over the past week 3, 4, 6
If symptoms occur ≥2 days per week or SABA use exceeds 2 days per week, therapy should be advanced to Step 2 with daily low-dose inhaled corticosteroids 1, 2, 3, 4, 6
Environmental triggers and comorbid conditions that may worsen asthma control should be evaluated 1, 2, 3

Older adults warrant additional attention to comorbidities that may complicate asthma management, but the fundamental approach of SABA as needed without daily controller therapy remains appropriate for intermittent asthma regardless of age 1, 2, 3, 4